You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plegridy®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

SARS-CoV Infection, Interferon, Covid19 Trial in Santiago (Peginterferon beta-1a)

Completed
  • SARS-CoV Infection
  • +2 more
  • Peginterferon beta-1a
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Sep 2, 2021

Plegridy Observational Program

Completed
  • Relapsing Forms of Multiple Sclerosis
  • peginterferon beta-1a
  • Homewood, Alabama
  • +151 more
Feb 10, 2022

Multiple Sclerosis, Exposure During Pregnancy Trial in Worldwide (Dimethyl fumarate, Peginterferon beta-1a)

Recruiting
  • Multiple Sclerosis
  • Exposure During Pregnancy
  • Dimethyl fumarate
  • Peginterferon beta-1a
  • Boston, Massachusetts
  • +16 more
Oct 21, 2021

Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • peginterferon beta-1a
  • +2 more
  • Amadora, Portugal
  • +14 more
Nov 23, 2020

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Italy (peginterferon beta-1a)

Completed
Has Results
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • peginterferon beta-1a
  • Arezzo, Italy
  • +29 more
Dec 24, 2019

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Multiple Sclerosis Trial in Teaneck (Plegridy, Prednisone, Tylenol Pill)

Unknown status
  • Multiple Sclerosis
  • Teaneck, New Jersey
    Holy Name Medical Center
Aug 13, 2019

Interferon Beta Therapy in Participants With Multiple Sclerosis

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • SC Peginterferon beta-1a
  • +2 more
  • Göttingen, Germany
    Research Site
Sep 24, 2019

EPID Multiple Sclerosis Pregnancy Study

Completed
  • Multiple Sclerosis
  • Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
  • +6 more
  • Multiple Locations, Finland
    Many locations
Aug 12, 2019

Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

Recruiting
  • Atrial Fibrillation
  • Heart rhythm measurements with Preventicus®
  • +3 more
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Aug 28, 2023

ECMO Braile Biomédica® in COVID-19 Patients

Recruiting
  • COVID-19
  • Patients underwent cardiorespiratory support
  • Lago Sul, Brasília - DF, Brazil
    Hospital Brasília
Oct 13, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

Recruiting
  • Venous Leg Ulcer
  • Diabetic Foot
  • AQUACEL® Ag+ Extra™
  • Cutimed® Sorbact®
  • Barranquilla, Colombia
  • +13 more
May 26, 2023

Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

Recruiting
  • Dental Implants
  • Dynamic Computer Assisted Surgery
  • Freehand
  • L´hospitalet de Llobregat, Catalunya, Spain
    University of Barcelona
Aug 31, 2023

Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

Not yet recruiting
  • Tricuspid Regurgitation
  • Tricuspid Valve Disease
  • TricValve® Transcatheter Bicaval Valve System
  • Medical Therapy Arm
  • Cleveland, Ohio
  • +10 more
Nov 14, 2023

Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

Completed
  • Carpal Tunnel Syndrome
  • KForce Sens
  • Baseline Electrıgoniometer
  • Denizli, Turkey
    Pamukkale University
Sep 14, 2023

Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)

Recruiting
  • Vaccine-Preventable Diseases
  • +2 more
  • Oral typhoid fever vaccine
  • Oral cholera vaccine
  • Helsinki, Finland
    Meilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023

Observatory on Cow's Milk Protein Allergy

Not yet recruiting
  • Food Allergy
  • Pepticate® Syneo®
  • Paris, France
    Hôpital Trousseau - APHP
Oct 10, 2023

Real Life of TLC-NOSF Dressings in Local Treatment of Chronic

Recruiting
  • Real Life Study
  • +4 more
  • TLC-NOSF dressings (D'URGOSTART PLUS® BORDER, URGOSTART PLUS® PAD and URGOSTART INTERFACE®)
  • Paris, France
    Pr Agnès HARTEMANN
Nov 13, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Aggressive Therapy or Traditional Therapy
  • Birmingham, Alabama
  • +51 more
Jan 23, 2023

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023